Faecal microbiota transplantation: an emerging solution for recurrent infections

Juliana Stupnik and Gerardo Laube

South Health and Policy, 2024, vol. 3, 122-122

Abstract: Clostridioides difficile infection was one of the main causes of antibiotic-associated diarrhoea, especially in Latin America, where its incidence increased considerably. Traditionally, it was treated with antibiotics such as metronidazole and vancomycin, although fidaxomicin emerged as a more effective option. However, the high recurrence rates prompted exploration of faecal microbiota transplantation (FMT), which proved more effective in recurrent cases. Although FMT was recognised as a promising therapy, its implementation in Latin America faced barriers such as a lack of protocols, infrastructure, regulation and cultural acceptance. Despite these challenges, scientific evidence supported its progressive incorporation into health systems.

Date: 2024
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:dbk:southh:2024v3a82

DOI: 10.56294/shp2024122

Access Statistics for this article

More articles in South Health and Policy from AG Editor (Argentina)
Bibliographic data for series maintained by Javier Gonzalez-Argote ().